AERAS GLOBAL TB VACCINE FOUNDATION – Trademark Portfolio
Entity Type: 03
AERAS GLOBAL TB VACCINE FOUNDATION holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AERAS. The owner is based in Bethesda, MD.
7500 Old Georgetown Road
Suite 800
Bethesda, MD 20814
Showing of trademarks Trademarks
Trademark Classifications
AERAS GLOBAL TB VACCINE FOUNDATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does AERAS GLOBAL TB VACCINE FOUNDATION have?
AERAS GLOBAL TB VACCINE FOUNDATION has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does AERAS GLOBAL TB VACCINE FOUNDATION file in?
AERAS GLOBAL TB VACCINE FOUNDATION files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are AERAS GLOBAL TB VACCINE FOUNDATION's most well-known trademarks?
AERAS GLOBAL TB VACCINE FOUNDATION's registered trademark portfolio includes well-known marks such as AERAS. These are among 2 currently registered trademarks in the portfolio.
What is AERAS GLOBAL TB VACCINE FOUNDATION's trademark registration success rate?
AERAS GLOBAL TB VACCINE FOUNDATION has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.